Project Details
Short title | Risk-stratified sequential treatment of de-novo post-transplant lymphoproliferative disorder (PTLD) with Ibrutinib and Rituximab (IR) and IR-CHOP |
---|---|
Status | Finished |
Effective start/end date | 1/12/15 → 31/12/23 |
Funding
- BLOODWISE
- Janssen-Cilag Limited